Latest Breaking News On - George clinical institute - Page 1 : comparemela.com

Results of the ZENITH-CKD trial provide evidence of the safety and efficacy profile of combination zibotentan plus dapagliflozin in patients with chronic kidney disease.

United statesSharon barrHiddo heerspinkBiopharmaceuticals researchGeorge clinical institute hiddo jl heerspinkAmerican society of nephrology kidney weekUniversity medical center groningenUniversity of groningenDepartment of clinical pharmacyGeorge clinical instituteAmerican societyNephrology kidney weekClinical pharmacyUniversity medical centerStandard deviationConfidence interval